Deep Learning Based Models for CRISPR/Cas Off-Target Prediction | JoVE Visualize

Area of Science:

Genomics
Bioinformatics
Computational Biology

Background:

CRISPR/Cas genome editing offers precise genetic modification but faces challenges with off-target effects (OTS).
Accurate prediction of OTS is crucial for safe clinical applications of CRISPR/Cas technology.
In silico methods, especially deep learning, are emerging as powerful tools for OTS prediction due to their ability to learn complex sequence features.

Purpose of the Study:

To review existing off-target site (OTS) prediction tools, focusing on deep learning methods.
To characterize datasets used for training and testing deep learning models for OTS prediction.
To evaluate and compare the performance of six prominent deep learning models for CRISPR/Cas OTS prediction.

Main Methods:

Reviewed current OTS prediction tools, emphasizing deep learning approaches.
Analyzed datasets utilized for deep learning model training and validation.
Evaluated six deep learning models (CRISPR-Net, CRISPR-IP, R-CRISPR, CRISPR-M, CrisprDNT, Crispr-SGRU) using six public datasets and the CRISPRoffT database.
Assessed model performance using metrics like Precision, Recall, F1 score, MCC, AUROC, and PRAUC.

Main Results:

Deep learning models demonstrate potential for predicting CRISPR/Cas off-target sites.
The inclusion of validated OTS datasets in training significantly enhanced model performance and prediction robustness, especially for imbalanced datasets.
CRISPR-Net, R-CRISPR, and Crispr-SGRU exhibited strong overall performance across various evaluation scenarios.
No single model consistently outperformed all others across all tested conditions.

Conclusions:

High-quality, validated off-target site data is essential for improving the accuracy and reliability of deep learning-based predictions.
Advanced deep learning architectures, when trained with appropriate data, can significantly enhance the prediction of CRISPR/Cas off-target sites.
Integrating robust prediction tools is vital for ensuring the safety and efficacy of CRISPR/Cas genome editing in clinical settings.